PUBLISHER: The Business Research Company | PRODUCT CODE: 1946729
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946729
Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) tests are widely used techniques for detecting and quantifying DNA (or RNA) in a given sample. These tests are typically carried out in automated thermal cyclers, which are designed to minimize the risk of cross-contamination. PCR and real-time PCR have various applications in fields such as cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays.
The primary products associated with PCR and real-time PCR testing include consumables, reagents, instruments, software, and various services. These tests leverage technologies such as quantitative PCR and digital PCR, which offer a range of applications in clinical diagnostics, life science research, industrial settings, and other fields. The market for PCR and real-time PCR testing is segmented by end-use, which includes academic and research institutes, pharmaceutical and biotechnology companies, clinical diagnostics labs and hospitals, and other entities.
Tariffs are impacting the PCR and real-time PCR testing market by increasing costs of imported thermal cyclers, optical detection systems, reagents, enzymes, plastics, and precision electronic components used in instruments and consumables. Clinical diagnostics laboratories and research institutes in North America and Europe are most affected due to reliance on imported instruments and reagents, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are elevating testing costs and slowing procurement of advanced systems. However, they are also encouraging localized reagent manufacturing, regional instrument assembly, and domestic supply chain development for critical molecular diagnostic components.
The pcr and realtime pcr testing market research report is one of a series of new reports from The Business Research Company that provides pcr and realtime pcr testing market statistics, including pcr and realtime pcr testing industry global market size, regional shares, competitors with a pcr and realtime pcr testing market share, detailed pcr and realtime pcr testing market segments, market trends and opportunities, and any further data you may need to thrive in the pcr and realtime pcr testing industry. This pcr and realtime pcr testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pcr and realtime pcr testing market size has grown strongly in recent years. It will grow from $11.12 billion in 2025 to $12.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of molecular diagnostics adoption, increasing prevalence of infectious diseases, growth of genomics research activities, rising use of pcr in clinical diagnostics, expansion of academic research infrastructure.
The pcr and realtime pcr testing market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of digital pcr technologies, expansion of decentralized diagnostic testing, growing investments in life science research, increasing use of pcr in oncology and genetic testing. Major trends in the forecast period include increasing adoption of high-throughput pcr platforms, rising demand for multiplex real-time pcr assays, growing integration of automated sample preparation systems, expansion of digital pcr applications, enhanced focus on contamination-free testing.
The increasing number of approvals for personalized medicines is anticipated to drive the growth of the PCR and real-time PCR testing market in the coming years. Personalized medicines are therapeutic products or treatments customized for individual patients and are developed based on a patient's genetic, biomarker, phenotypic, or psychosocial characteristics that can influence treatment response. PCR and real-time PCR play a critical role in personalized medicine by enabling accurate identification of genetic variations, which supports the customization of treatments and optimization of therapeutic outcomes. For example, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared to six approvals in 2022. Therefore, the growing approvals for personalized medicines are contributing to the expansion of the PCR and real-time PCR testing market.
Major companies operating in the PCR and real-time PCR testing market are developing highly specific detection kits, including variant-targeted RT-PCR assays, to improve the tracking of viral evolution and support epidemiological surveillance. Variant-targeted RT-PCR assays are molecular diagnostic tests designed to identify specific genetic mutations or variations within a virus, allowing accurate detection of particular viral strains or sub-variants. For example, in January 2023, Roche, a Switzerland-based diagnostics company, launched the VirSNiP SARS-CoV-2 Spike F486P assay, a real-time PCR test that specifically identifies the F486P mutation in the XBB.1.5 Omicron sub-variant. The assay operates on standard real-time PCR platforms such as the LightCycler 480 II and cobas z 480 and provides precise lineage differentiation to support effective variant monitoring.
In February 2025, Bio-Rad Laboratories, a US-based provider of life science research and clinical diagnostics products, acquired Stilla Technologies for an undisclosed amount. Through this acquisition, Bio-Rad intends to incorporate Stilla's next-generation digital PCR systems into its portfolio to drive innovation in molecular diagnostics across applications including infectious disease testing, oncology, and cell therapy. Stilla Technologies is a US-based developer of all-in-one digital PCR platforms, consumables, and assays designed for high-multiplex and high-throughput molecular testing.
Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc.
Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pcr and realtime pcr testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The PCR and Real-time PCR testing market consists of sales of genetic sequencing equipment such as automated thermo cyclers with technologies such as quantitative PCR and digital PCR for cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
PCR And Realtime PCR Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pcr and realtime pcr testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pcr and realtime pcr testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pcr and realtime pcr testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.